GCP
VANI icon

GSA Capital Partners’s Vivani Medical VANI Stock Holding History

GSA Capital Partners’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75K Buy
+60,866
New +$73.6K ﹤0.01% 1645

Other funds holding VANI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

GSA Capital Partners's VANI Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Vivani Medical (VANI) in Q2 2026: 60,866 shares worth $75K. The stake represents ﹤0.01% of the portfolio and ranks #1645 among its holdings.

27 funds tracked by Wall St. Rank hold VANI as of Q2 2026.

  • GSA Capital Partners held 60,866 shares of Vivani Medical worth $75K as of Q2 2026.
  • Vivani Medical was a new GSA Capital Partners position in Q2 2026.
  • Vivani Medical made up ﹤0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1645 holding.
  • 27 funds tracked by Wall St. Rank held Vivani Medical as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.